首页> 外文期刊>Iranian Journal of Pathology >CORRELATION OF HER-2/NEU AND TP53 EXPRESSIONS WITH CLINICOPATHOLOGIC CHARACTERISTICS IN INFILTRATIVE DUCTAL BREAST CARCINOMAS
【24h】

CORRELATION OF HER-2/NEU AND TP53 EXPRESSIONS WITH CLINICOPATHOLOGIC CHARACTERISTICS IN INFILTRATIVE DUCTAL BREAST CARCINOMAS

机译:HER2 / NEU和TP53表达与渗透性导管癌的临床病理特征的相关性

获取原文
       

摘要

Objective: To review Her-2eu and Tp53 status and their correlation with all other prognostic clinicopathologic features of infiltrative ductal breast carcinomas.Materials and Methods: This cross sectional study was performed on 139 patients with infiltrative ductal breast carcinoma who were diagnosed between May 2000 and March 2006 at the surgery and pathology departments of Alzahra Hospital, Isfahan, Iran. Immunostaining (IHC) for Tp53 and Her-2eu were performed on formalin-fixed, paraffin-embedded tissues based on an avidin-biotinperoxidase complex technique. The relationship of these markers with clinicpathologic parameters including age, axillary lymph nodes status, tumor size and histological grade were evaluated.Results: It was found out that Her-2eu-positive cases were greater among metastatic lymph nodes than in patients without metastasis, however it was not significant (p=0.1). A significant association was also observed between Her-2eu status and tumor grading (p=0.01). On the contrary, no association was found with other clinicpathologic parameters. In this study, Tp53 presentation in high-grade carcinomas was significantly more as compared to low grade ones (p=0.03). A significant association was also observed between Tp53 and tumor size (p =0.01). There was no association with menopausal status and lymph node status.Conclusion: IHC determined that Her-2eu and Tp53 expressions are not associated with nodal and menopause status. Conversely, a correlation was found between Her-2eu, Tp53 expressions and high histological grade of tumor. However, to validate these findings, long-term prospective studies on patients’ survival are necessary.
机译:目的:探讨Her-2 / neu和Tp53的状态及其与浸润性导管癌的所有其他预后临床病理特征的相关性。材料与方法:本横断面研究针对139例于5月间被诊断为浸润性导管癌的患者进行。 2000年和2006年3月在伊朗伊斯法罕市Alzahra医院的外科和病理科工作。基于亲和素-生物素过氧化物酶复合物技术,在福尔马林固定的石蜡包埋组织上进行了Tp53和Her-2 / neu的免疫染色(IHC)。研究了这些标志物与年龄,腋窝淋巴结状况,肿瘤大小和组织学分级等临床病理参数的关系。结果:发现转移性淋巴结中Her-2 / neu阳性病例比无转移的患者大。 ,但不显着(p = 0.1)。在Her-2 / neu状态与肿瘤分级之间也发现了显着关联(p = 0.01)。相反,未发现与其他临床病理参数相关。在这项研究中,与低度恶性肿瘤相比,高恶性肿瘤中Tp53的表达明显更高(p = 0.03)。在Tp53与肿瘤大小之间也观察到显着相关性(p = 0.01)。结论:IHC确定Her-2 / neu和Tp53的表达与淋巴结和更年期状态无关。相反,在Her-2 / neu,Tp53表达与肿瘤的高组织学等级之间发现了相关性。但是,为了验证这些发现,有必要对患者的生存进行长期的前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号